Article

Plantar fascia-specific stretching exercise improves outcomes in patients with chronic plantar fasciitis - A prospective clinical trial with two-year follow-up

Department of Orthopaedics, University of Rochester School of Medicine and Dentistry, 601 Elmwood Avenue, Box 665, Rochester, NY 14620, USA.
The Journal of Bone and Joint Surgery (Impact Factor: 4.31). 09/2006; 88(8):1775-81. DOI: 10.2106/JBJS.E.01281
Source: PubMed

ABSTRACT In a previous investigation, eighty-two patients with chronic proximal plantar fasciitis for a duration of more than ten months completed a randomized, prospective clinical trial. The patients received instructions for either a plantar fascia-stretching protocol or an Achilles tendon-stretching protocol and were evaluated after eight weeks. Substantial differences were noted in favor of the group managed with the plantar fascia-stretching program. The goal of this two-year follow-up study was to evaluate the long-term outcomes of the plantar fascia-stretching protocol in patients with chronic plantar fasciitis.
Phase one of the clinical trial concluded at eight weeks. At the eight-week follow-up evaluation, all patients were instructed in the plantar fascia-stretching protocol. At the two-year follow-up evaluation, a questionnaire consisting of the pain subscale of the Foot Function Index and an outcome survey related to pain, function, and satisfaction with treatment was mailed to the eighty-two subjects who had completed the initial clinical trial. Data were analyzed with use of a mixed-model analysis of covariance for each outcome of interest.
Complete data sets were obtained from sixty-six patients. The two-year follow-up results showed marked improvement for all patients after implementation of the plantar fascia-stretching exercises, with an especially high rate of improvement for those in the original group treated with the Achilles tendon-stretching program. In contrast to the eight-week results, the two-year results showed no significant differences between the groups with regard to the worst pain or pain with first steps in the morning. Descriptive analysis of the data showed that 92% (sixty-one) of the sixty-six patients reported total satisfaction or satisfaction with minor reservations. Fifty-one patients (77%) reported no limitation in recreational activities, and sixty-two (94%) reported a decrease in pain. Only sixteen of the sixty-six patients reported the need to seek treatment by a clinician.
This study supports the use of the tissue-specific plantar fascia-stretching protocol as the key component of treatment for chronic plantar fasciitis. Long-term benefits of the stretch include a marked decrease in pain and functional limitations and a high rate of satisfaction. This approach can provide the health-care practitioner with an effective, inexpensive, and straightforward treatment protocol.

1 Bookmark
 · 
316 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Objectives: Ultrasound-guided corticosteroid injection is an effective treatment for plantar fasciitis. We aimed to examine whether the eight scales of the Short Form-36 [SF-36] quality of life questionnaire could predict outcome of ultrasound-guided corticosteroid injection for plantar fasciitis. Methods: Sixteen patients [mean age 55.7 years] with unilateral plantar fasciitis received ultrasound-guided corticosteroid injections and all evaluations. The SF-36 questionnaire was administered and tenderness threshold [TT] was measured before injection, at 3 weeks, and at 3 months post-injection. Differences in the eight SF-36 scales among the three time points were examined. Furthermore, baseline measurements and changes in the SF-36 scales were examined for their association with changes in TT at 3 weeks and 3 months post-injection. Results: The scale “bodily pain” [BP] decreased significantly after injection [baseline versus 3 months post-injection: 46.25 ± 11.73 versus 63.06 ± 18.26; p = 0.036]. Baseline BP correlated with change in TT at 3 weeks [r = −0.554, p = 0.026]. The change in BP correlated with change in TT at 3 weeks [r = 0.594, p = 0.015] and at 3 months [r = 0.536, p = 0.032]. Conclusion: The BP scale can be used to predict the outcome of ultrasound-guided corticosteroid injection for plantar fasciitis. Less initial bodily pain leads to less improvement in objective inferior heel tenderness.
    Journal of Musculoskeletal Pain 05/2014; DOI:10.3109/10582452.2014.907854 · 0.32 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Heel pain is commonly encountered in orthopaedic practice. Establishing an accurate diagnosis is critical, but it can be challenging due to the complex regional anatomy. Subacute and chronic plantar and medial heel pain are most frequently the result of repetitive microtrauma or compression of neurologic structures, such as plantar fasciitis, heel pad atrophy, Baxter nerve entrapment, calcaneal stress fracture, and tarsal tunnel syndrome. Most causes of inferior heel pain can be successfully managed nonsurgically. Surgical intervention is reserved for patients who do not respond to nonsurgical measures. Although corticosteroid injections have a role in the management of select diagnoses, they should be used with caution.
    The Journal of the American Academy of Orthopaedic Surgeons 06/2014; 22(6):372-380. DOI:10.5435/JAAOS-22-06-372 · 2.40 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Plantar fasciitis is the most common cause of heel pain. Extracorporeal shock wave therapy (ESWT) is an alternative treatment for refractory cases of plantar fasciitis. Studies also demonstrated that ESWT may be an appropriate treatment for myofascial trigger points. This study was designed to evaluate its effectiveness by comparing the ESWT of Gastrocnemius/Soleus (gastroc-soleus) trigger points and heel region with the ESWT of the heel region alone. The study was carried out among 40 patients with a clinical diagnosis of plantar fasciitis, divided randomly to case (n = 20) and control (n = 20) groups. The case group received ESWT for the heel region and for the gastroc-soleus trigger points. The control group received ESWT just for the heel region. The protocol was the same in both groups and they were treated for three sessions every week. The pain score (100 mm visual analog score [VAS]) and the modified Roles and Maudsley score was evaluated before the first session and eight weeks after the last session. Eight weeks after the last session, although the mean VAS had decreased significantly in both groups, this decrement was more significant in the case group. (P = 0.04). According to the modified Roles and Maudsley score, there was a significant improvement in both the case (P < 0.001) and control (P = 0.01) groups, eight weeks after treatment, but there were significantly better results in the case group. The combination of ESWT for both plantar fasciitis and gastroc-soleus trigger points in treating patients with plantar fasciitis is more effective than utilizing it solely for plantar fasciitis.
    03/2014; 3:99. DOI:10.4103/2277-9175.129369
    This article is viewable in ResearchGate's enriched format

Preview

Download
31 Downloads
Available from